(JDEP) Jde Peets - Ratings and Ratios
Coffee, Tea, Capsules, Instant, Pods
Dividends
| Dividend Yield | 3.41% |
| Yield on Cost 5y | 3.78% |
| Yield CAGR 5y | 25.99% |
| Payout Consistency | 98.0% |
| Payout Ratio | 58.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 4.44% |
| Value at Risk 5%th | 6.33% |
| Relative Tail Risk | -13.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.96 |
| Alpha | 70.89 |
| CAGR/Max DD | 0.21 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.423 |
| Beta | -0.152 |
| Beta Downside | 0.143 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.48% |
| Mean DD | 16.98% |
| Median DD | 14.21% |
Description: JDEP Jde Peets October 30, 2025
JDE Peet’s N.V. (ticker JDEP) is a global coffee-and-tea conglomerate organized into four geographic segments-Europe, LARMEA, APAC, and Peet’s. Its product portfolio spans roast-and-ground multi-serve coffee, single-serve pads and capsules, instant coffee, premium tea, liquid-roast beverages, coffee-machine hardware, and related services. Core brands include L’OR, Peet’s, Jacobs, Senseo, Tassimo, Douwe Egberts, Old Town, Pickwick and Moccona, serving B2B channels (offices, hotels, bars, restaurants) as well as its own retail coffee stores. The company traces its origins to 1753, is headquartered in Amsterdam, and operates as a subsidiary of Acorn Holdings B.V.
Key recent metrics indicate FY 2023 revenue of roughly €7.3 billion, with an adjusted EBITDA margin hovering around 12 %, reflecting steady profitability despite volatile coffee-bean prices. The premium-coffee segment-particularly single-serve capsules under the L’OR and Senseo brands-has been growing at an annualized 6-8 % rate, driven by consumer willingness to pay for convenience and perceived quality. Macro-level drivers such as global inflation pressures and shifting consumer spending patterns on discretionary items remain material risks, while the ongoing “coffee-as-a-service” trend (e.g., subscription models and office-centric supply contracts) offers a potential upside.
For a deeper dive into JDEP’s valuation metrics and peer comparison, the ValueRay platform offers a concise, data-rich snapshot worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (550.5m TTM) > 0 and > 6% of Revenue (6% = 737.2m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -3.82pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -22.57% (prev -8.97%; Δ -13.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 1.25b > Net Income 550.5m (YES >=105%, WARN >=100%) |
| error: Net Debt/EBITDA cannot be calculated |
| Current Ratio 0.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (485.5m) change vs 12m ago -1.35% (target <= -2.0% for YES) |
| Gross Margin 36.85% (prev 36.73%; Δ 0.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.67% (prev 44.42%; Δ 8.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.54 (EBITDA TTM 1.88b / Interest Expense TTM 94.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.05
| (A) -0.12 = (Total Current Assets 4.25b - Total Current Liabilities 7.02b) / Total Assets 23.52b |
| (B) 0.08 = Retained Earnings (Balance) 1.85b / Total Assets 23.52b |
| (C) 0.05 = EBIT TTM 1.08b / Avg Total Assets 23.33b |
| (D) 0.15 = Book Value of Equity 1.85b / Total Liabilities 12.69b |
| Total Rating: -0.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.23
| 1. Piotroski 5.0pt |
| 2. FCF Yield 5.67% |
| 3. FCF Margin 6.64% |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC (= 0.87)% |
| 7. RoE 5.03% |
| 8. Rev. Trend -12.05% |
| 9. EPS Trend 2.70% |
What is the price of JDEP shares?
Over the past week, the price has changed by +0.06%, over one month by +0.25%, over three months by +1.22% and over the past year by +74.47%.
Is JDEP a buy, sell or hold?
What are the forecasts/targets for the JDEP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.5 | -6.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36.7 | 15.9% |
JDEP Fundamental Data Overview December 06, 2025
Market Cap EUR = 15.31b (15.31b EUR * 1.0 EUR.EUR)
P/E Trailing = 25.6748
P/E Forward = 16.1551
P/S = 1.5834
P/B = 1.4177
P/EG = 1.253
Beta = 0.233
Revenue TTM = 12.29b EUR
EBIT TTM = 1.08b EUR
EBITDA TTM = 1.88b EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 14.38b EUR (15.31b + (null Debt) - CCE 937.0m)
Interest Coverage Ratio = 11.54 (Ebit TTM 1.08b / Interest Expense TTM 94.0m)
FCF Yield = 5.67% (FCF TTM 815.5m / Enterprise Value 14.38b)
FCF Margin = 6.64% (FCF TTM 815.5m / Revenue TTM 12.29b)
Net Margin = 4.48% (Net Income TTM 550.5m / Revenue TTM 12.29b)
Gross Margin = 36.85% ((Revenue TTM 12.29b - Cost of Revenue TTM 7.76b) / Revenue TTM)
Gross Margin QoQ = 35.12% (prev 35.12%)
Tobins Q-Ratio = 0.61 (Enterprise Value 14.38b / Total Assets 23.52b)
Interest Expense / Debt = unknown (Interest Expense 51.0m / Debt none)
Taxrate = 36.19% (97.0m / 268.0m)
NOPAT = 692.0m (EBIT 1.08b * (1 - 36.19%))
Current Ratio = 0.61 (Total Current Assets 4.25b / Total Current Liabilities 7.02b)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 1.88b)
Debt / FCF = unknown (Net Debt none / FCF TTM 815.5m)
Total Stockholder Equity = 10.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.34% (Net Income 550.5m / Total Assets 23.52b)
RoE = 5.03% (Net Income TTM 550.5m / Total Stockholder Equity 10.95b)
RoCE = 6.58% (EBIT 1.08b / Capital Employed (Total Assets 23.52b - Current Liab 7.02b))
RoIC = 6.32% (NOPAT 692.0m / Invested Capital 10.95b)
WACC = 5.45% (E(15.31b)/V(15.31b) * Re(5.45%) + (debt-free company))
Discount Rate = 5.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.98%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈1.16b ; Y1≈764.4m ; Y5≈349.6m
Fair Price DCF = 14.17 (DCF Value 6.87b / Shares Outstanding 485.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 2.70 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: -12.05 | Revenue CAGR: 6.78% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=1.89 | Chg30d=-0.002 | Revisions Net=+0 | Growth EPS=-1.5% | Growth Revenue=+2.4%